Blocking histamine receptor H1 on macrophages with anti-allergy drugs restores T-cell anti-tumor immunity.

被引:0
|
作者
Li, Hongzhong [1 ]
Xiao, Yi [1 ]
Yao, Jun [1 ]
Yuan, Xiangliang [1 ]
Yin, Xuedong [1 ]
Zhang, Yuan [1 ]
Saito, Yohei [1 ]
Yagita, Hideo [2 ]
Gibbons, Don [1 ]
Yu, Dihua [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Juntendo Univ, Sch Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2794
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma
    Wu, Lei
    Yu, Guang-Tao
    Deng, Wei-Wei
    Mao, Liang
    Yang, Lei-Lei
    Ma, Si-Rui
    Bu, Lin-Lin
    Kulkarni, Ashok B.
    Zhang, Wen-Feng
    Zhang, Lu
    Sun, Zhi-Jun
    ONCOIMMUNOLOGY, 2018, 7 (04):
  • [22] Radiofrequency thermal ablation of hepatocellular carcinoma may activate regulatory T cells blocking anti-tumor T-cell responses
    Zerbini, A.
    Pilli, M.
    Pelosi, G.
    Menozzi, G.
    Laccabue, D.
    Cerioni, S.
    Pizzi, M. G.
    Schivazappa, S.
    Fagnoni, F.
    Ferrari, C.
    Missale, G.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S147 - S148
  • [23] Photochemical delivery of bleomycin induces T-cell activation of importance for curative effect and systemic anti-tumor immunity
    Norum, Ole-Jacob
    Fremstedal, Ane Sofie Viset
    Weyergang, Anette
    Golab, Jakub
    Berg, Kristian
    JOURNAL OF CONTROLLED RELEASE, 2017, 268 : 120 - 127
  • [24] Triggering of TNFRSF25 promotes CD8+ T-cell responses and anti-tumor immunity
    Slebioda, Tomasz J.
    Rowley, Tania F.
    Ferdinand, John R.
    Willoughby, Jane E.
    Buchan, Sarah L.
    Taraban, Vadim Y.
    Al-Shamkhani, Aymen
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (09) : 2606 - 2611
  • [25] Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy
    Mantilla-Rojas, Carolina
    Velasquez, Fred C.
    Morton, Janelle E.
    Clemente, Leticia C.
    Parra, Edwin R.
    Torres-Cabala, Carlos
    Sevick-Muraca, Eva M.
    CANCERS, 2022, 14 (07)
  • [26] Arenobufagin enhances T-cell anti-tumor immunity in colorectal cancer by modulating HSP90β accessibility
    Shang, Zhihao
    Fan, Yiping
    Xi, Songyang
    Zhang, Shang
    Shen, Weixing
    Tao, Lihuiping
    Xu, Changliang
    Tan, Jiani
    Fan, Minmin
    Ma, Hongyue
    Lai, Yueyang
    Sun, Dongdong
    Cheng, Haibo
    PHYTOMEDICINE, 2024, 128
  • [27] Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
    Muraro, Elena
    Del Ben, Fabio
    Turetta, Matteo
    Cesselli, Daniela
    Bulfoni, Michela
    Zamarchi, Rita
    Rossi, Elisabetta
    Spazzapan, Simon
    Dolcetti, Riccardo
    Steffan, Agostino
    Brisotto, Giulia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Role of Foxo1 and inflammation on T-cell exhaustion in the course of anti-tumor responses
    Lombes, Amelie
    Germain, Mathieu
    Durand, Aurelie
    Giraud, Lea
    Blondel, Armelle
    Auffray, Cedric
    Lucas, Bruno
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 246 - 246
  • [29] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
    Li, Baoqi
    Fang, Tianliang
    Li, Yuan
    Xue, Tianyuan
    Zhang, Zhirang
    Li, Liyan
    Meng, Fanqiang
    Wang, Jinqiang
    Hou, Linlin
    Liang, Xin
    Zhang, Xudong
    Gu, Zhen
    NANO TODAY, 2022, 46
  • [30] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
    Li, Baoqi
    Fang, Tianliang
    Li, Yuan
    Xue, Tianyuan
    Zhang, Zhirang
    Li, Liyan
    Meng, Fanqiang
    Wang, Jinqiang
    Hou, Linlin
    Liang, Xin
    Zhang, Xudong
    Gu, Zhen
    Nano Today, 2022, 46